Classification and Current Treatment of Hepatocellular Carcinoma
| Autor: | Robert Elliott, Sathya Ram, Vinit Khanna |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Oncology
medicine.medical_specialty Cirrhosis business.industry Radiofrequency ablation Surgical care Hepatitis C virus General Medicine medicine.disease medicine.disease_cause Transarterial Radioembolization digestive system diseases Review article law.invention 03 medical and health sciences 0302 clinical medicine law 030220 oncology & carcinogenesis Internal medicine Hepatocellular carcinoma medicine 030211 gastroenterology & hepatology business Primary liver cancer neoplasms |
| Zdroj: | American Journal of Interventional Radiology. 2:8 |
| ISSN: | 2572-4606 2572-4614 |
| DOI: | 10.25259/ajir-21-2018 |
| Popis: | Hepatocellular carcinoma (HCC) is an aggressive primary liver cancer that arises in a background of hepatic cirrhosis. In the United States, HCC has been increasing due to an increasing prevalence of the Hepatitis C virus which causes cirrhosis. Curative treatment of HCC is indicated when tumors are small and may include surgical resection, liver transplant, or radiofrequency ablation. Locoregional treatment includes transarterial chemoembolization and transarterial radioembolization which can be used as eithera an adjunct to surgical care or as primary therapy. This review article will examine the initial surveillance of patients at risk for HCC, the current guidelines related to diagnosis and staging of HCC, and will conclude with a review of best practices related to the treatment of HCC. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|